261
Views
12
CrossRef citations to date
0
Altmetric
Original Research

A cultural adaptation and validation study of a self-report measure of the extent of and reasons for medication nonadherence among patients with diabetes in Singapore

, , , , , , , , , , , , , , , , , & show all
Pages 1241-1252 | Published online: 29 Jul 2019

References

  • Thomas CC, Philipson LH. Update on diabetes classification. Med Clin North Am. 2015;99(1):1–16. doi:10.1016/j.mcna.2014.08.01525456640
  • Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137–149. doi:10.1016/j.diabres.2013.11.00224630390
  • Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care. 2005;43(6):517–520.15908845
  • Teo V, Toh MR, Kwan YH, Raaj S, Tan SY, Tan JZ. Association between total daily doses with duration of hospitalization among readmitted patients in a multi-ethnic Asian population. Saudi Pharm J. 2015;23(4):388–396. doi:10.1016/j.jsps.2015.01.01327134540
  • Toh MR, Teo V, Kwan YH, Raaj S, Tan SY, Tan JZ. Association between number of doses per day, number of medications and patient’s non-compliance, and frequency of readmissions in a multi-ethnic Asian population. Preventive Med Reports. 2014;1:43–47. doi:10.1016/j.pmedr.2014.10.001
  • Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27(9):2149–2153. doi:10.2337/diacare.27.9.214915333476
  • Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–1841. doi:10.1001/archinte.166.17.183617000939
  • Lerman I. Adherence to treatment: the key for avoiding long-term complications of diabetes. Arch Med Res. 2005;36(3):300–306. doi:10.1016/j.arcmed.2004.12.00115925020
  • DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–209.15076819
  • Lin LK, Sun Y, Heng BH, Chew DEK, Chong PN. Medication adherence and glycemic control among newly diagnosed diabetes patients. BMJ Open Diabetes Res Care. 2017;5(1):e000429. doi:10.1136/bmjdrc-2017-000429
  • Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2014;20(11):CD000011. doi:10.1002/14651858.CD000011.pub4
  • Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26(5):331–342.11679023
  • Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. doi:10.1056/NEJMra05010016079372
  • Voils CI, Hoyle RH, Thorpe CT, Maciejewski ML, Yancy WS Jr. Improving the measurement of self-reported medication nonadherence. J Clin Epidemiol. 2011;64(3):250–254. doi:10.1016/j.jclinepi.2010.07.01421194887
  • Odegard PS, Capoccia K. Medication taking and diabetes. Diabetes Educ. 2007;33(6):1014–1029. doi:10.1177/014572170730840718057270
  • Moon SJ, Lee WY, Hwang JS, Hong YP, Morisky DE. Accuracy of a screening tool for medication adherence: a systematic review and meta-analysis of the morisky medication adherence scale-8. PLoS One. 2017;12(11):e0187139. doi:10.1371/journal.pone.018713929095870
  • Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000;42(3):241–247.10785582
  • Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the hill-bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000;15(3):90–96.10951950
  • Koschack J, Marx G, Schnakenberg J, Kochen MM, Himmel W. Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties. J Clin Epidemiol. 2010;63(3):299–306. doi:10.1016/j.jclinepi.2009.06.01119762213
  • Voils CI, Maciejewski ML, Hoyle RH, et al. Initial validation of a self-report measure of the extent of and reasons for medication nonadherence. Med Care. 2012;50(12):1013–1019. doi:10.1097/MLR.0b013e318269e12122922431
  • Voils CI, King HA, Neelon B, et al. Characterizing weekly self-reported antihypertensive medication nonadherence across repeated occasions. Patient Prefer Adherence. 2014;8:643–650. doi:10.2147/PPA.S6071524855340
  • Blalock DV, Zullig LL, Bosworth HB, Taylor SS, Voils CI. Self-reported medication nonadherence predicts cholesterol levels over time. J Psychosom Res. 2019. doi:10.1016/j.jpsychores.2019.01.010
  • Weidenbacher HJ, Beadles CA, Maciejewski ML, Reeve BB, Voils CI. Extent and reasons for nonadherence to antihypertensive, cholesterol, and diabetes medications: the association with depressive symptom burden in a sample of American veterans. Patient Prefer Adherence. 2015;9:327–336. doi:10.2147/PPA.S7453125759567
  • Wong WK. Census of Population 2010. Statistical Release 1: Demographic Characteristics, Education, Language and Religion. Singapore:: Singapore Department of Statistics; 2011.
  • Lee WR. The changing demography of diabetes mellitus in Singapore. Diabetes Res Clin Pract. 2000;50(Suppl 2):S35–S39.11024582
  • Wong LY, Toh MP, Tham LW. Projection of prediabetes and diabetes population size in Singapore using a dynamic Markov model. J Diabetes. 2017;9(1):65–75. doi:10.1111/1753-0407.1238426849033
  • Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation Process for Patient-Reported Outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8(2):94–104. doi:10.1111/j.1524-4733.2005.04054.x15804318
  • Culig J, Leppee M, Boskovic J, Eric M. Determining the difference in medication compliance between the general patient population and patients receiving antihypertensive therapy: a case study. Arch Pharm Res. 2011;34(7):1143–1152. doi:10.1007/s12272-011-0712-021811921
  • Nau DP, Steinke DT, Williams LK, et al. Adherence analysis using visual analog scale versus claims-based estimation. Ann Pharmacother. 2007;41(11):1792–1797. doi:10.1345/aph.1K26417925497
  • Wang P, Luo N, Tai ES, Thumboo J. The EQ-5D-5L is more discriminative than the EQ-5D-3L in patients with diabetes in Singapore. Value Health Reg Issues. 2016;9:57–62. doi:10.1016/j.vhri.2015.11.00327881260
  • Leung AA, Daskalopoulou SS, Dasgupta K, et al. Hypertension Canada’s 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults. Can J Cardiol. 2017;33(5):557–576. doi:10.1016/j.cjca.2017.03.00528449828
  • Prinsen CA, Mokkink LB, Bouter LM, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1147–1157. doi:10.1007/s11136-018-1798-329435801
  • Grant S, Aitchison T, Henderson E, et al. A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise. Chest. 1999;116(5):1208–1217. doi:10.1378/chest.116.5.120810559077
  • Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality Life Res. 2011;20(10):1727–1736. doi:10.1007/s11136-011-9903-x
  • Wang Y, Tan N-C, Tay E-G, Thumboo J, Luo N. Cross-cultural measurement equivalence of the 5-level EQ-5D (EQ-5D-5L) in patients with type 2 diabetes mellitus in Singapore. Health Qual Life Outcomes. 2015;13:103. doi:10.1186/s12955-015-0297-226179285
  • Strube MJ. Effect indicator versus causal indicator measurement. Encycl Clin Psychol. 2014;1–5.
  • Mokkink LB, Terwee CB, Patrick DL, et al. COSMIN Checklist Manual. Amsterdam: University Medical Center 2012.
  • Ursachi G, Horodnic IA, Zait A. How reliable are measurement scales? External factors with indirect influence on reliability estimators. Procedia Econ Finance. 2015;20:679–686. doi:10.1016/S2212-5671(15)00123-9
  • Bland JM, Altman DG. Cronbach’s alpha. BMJ. 1997;314(7080):572. doi:10.1136/bmj.314.7080.5729055718
  • Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–163. doi:10.1016/j.jcm.2016.02.01227330520
  • McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods. 1996;1(1):30. doi:10.1037/1082-989X.1.1.30
  • Cohen HW, Shmukler C, Ullman R, Rivera CM, Walker EA. Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c). Diabet Med. 2010;27(2):210–216. doi:10.1111/j.1464-5491.2009.02898.x20546266
  • Kastien-Hilka T, Rosenkranz B, Schwenkglenks M, Bennett BM, Sinanovic E. Association between health-related quality of life and medication adherence in pulmonary tuberculosis in South Africa. Front Pharmacol. 2017;8:919. doi:10.3389/fphar.2017.0091929326591
  • Mukaka MM. Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2012;24(3):69–71.23638278
  • Marsh HW, Balla JR, McDonald RP. Goodness-of-fit indexes in confirmatory factor analysis: the effect of sample size. Psychol Bull. 1988;103(3):391. doi:10.1037/0033-2909.103.3.391
  • Mokkink LB, Prinsen C, Patrick DL, et al. COSMIN Methodology for Systematic Reviews of Patient-reported Outcome Measures (proms). User manual. 2018;78:1.
  • Bialosiewicz S, Murphy K, Berry T. An introduction to measurement invariance testing: resource packet for participants. Am Eval Assoc. 2013;1–37.
  • Chen FF. Sensitivity of goodness of fit indexes to lack of measurement invariance. Struct Equation Model. 2007;14(3):464–504. doi:10.1080/10705510701301834
  • Bollen K, Lennox R. Conventional wisdom on measurement: a structural equation perspective. Psychol Bull. 1991;110(2):305. doi:10.1037/0033-2909.110.2.305
  • Van de Mortel TF. Faking it: social desirability response bias in self-report research. Aust J Adv Nurs. 2008;25(4):40.
  • Wang Y, Lee J, Toh MP, Tang WE, Ko Y. Validity and reliability of a self-reported measure of medication adherence in patients with Type 2 diabetes mellitus in Singapore. Diabet Med. 2012;29(9):e338–e344. doi:10.1111/j.1464-5491.2012.03733.x22672497
  • Tarrant MA, Manfredo MJ. Digit preference, recall bias, and nonresponse bias in self reports of angling participation. Leisure Sci. 1993;15(3):231–238. doi:10.1080/01490409309513202
  • Fan JH, Lyons SA, Goodman MS, Blanchard MS, Kaphingst KA. Relationship between health literacy and unintentional and intentional medication nonadherence in medically underserved patients with type 2 diabetes. Diabetes Educ. 2016;42(2):199–208. doi:10.1177/014572171562496926763625
  • Wroe AL. Intentional and unintentional nonadherence: a study of decision making. J Behav Med. 2002;25(4):355–372.12136497
  • Streiner DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess. 2003;80(1):99–103. doi:10.1207/S15327752JPA8001_1812584072
  • Nazir R, Ur S, Azmi Hassali M, Saleem F, Bashir S, Aljadhey H. Does adherence to the therapeutic regimen associate with health related quality of life: findings from an observational study of type 2 diabetes mellitus patients in Pakistan. Pak J Pharm Sci. 2017;30(6):2159–2165.
  • Shiyanbola OO, Brown CM, Ward EC. “I did not want to take that medicine”: African-Americans’ reasons for diabetes medication nonadherence and perceived solutions for enhancing adherence. Patient Prefer Adherence. 2018;12:409–421. doi:10.2147/PPA.S15214629593383
  • McNary A. Avoiding risk with nonadherent patients. Innov Clin Neurosci. 2015;12(3–4):37–40.25973325
  • Shi L, Liu J, Fonseca V, Walker P, Kalsekar A, Pawaskar M. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes. 2010;8:99. doi:10.1186/1477-7525-8-9920836888
  • Stolpe S, Kroes MA, Webb N, Wisniewski T. A systematic review of insulin adherence measures in patients with diabetes. J Manag Care Spec Pharm. 2016;22(11):1224–1246. doi:10.18553/jmcp.2016.22.11.122427783551